Download PDF
Dtsch Med Wochenschr 2006; 131(4): 165-171
DOI: 10.1055/s-2006-924941
Übersichten
Onkologie
© Georg Thieme Verlag Stuttgart · New York

Hirnmetastasen beim Lungenkarzinom

Brain metastases of lung cancerD. Binder1 , B. Temmesfeld-Wollbrück1 , R. Wurm2 , C. Woiciechowsky3 , C. Schäper1 , D. Schürmann1 , N. Suttorp1 , T. Beinert4
  • 1Medizinische Klinik m. S. Infektiologie und Pneumologie, Charité - Universitätsmedizin Berlin
  • 2Klinik für Strahlentherapie, Campus Mitte, Charité - Universitätsmedizin Berlin
  • 3Klinik für Neurochirurgie, Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin
  • 4Abteilung Hämatologie und internistische Onkologie, Klinik Wartenberg
Further Information

Publication History

eingereicht: 8.4.2005

akzeptiert: 20.10.2005

Publication Date:
23 January 2006 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Die zerebrale Metastasierung ist eine häufige, insbesondere beim kleinzelligen und nicht-kleinzelligen Lungenkarzinom vorkommende Tumormanifestation. Die Hirnmetastasierung bestimmt oftmals die Prognose des Patienten und bedarf daher einer raschen Therapie. Unter Berücksichtigung der Tumorentität, der vorangegangenen Therapien, des Alters und Allgemeinzustandes des Patienten, der Anzahl der Metastasen sowie der extrazerebralen Tumoraktivität müssen für den Patienten individuelle, multimodale Behandlungspläne erstellt werden.

Am längsten überleben Patienten mit nicht-kleinzelligem Bronchialkarzinom und solitärer zerebraler Raumforderung nach kompletter Resektion oder stereotaktischer Radiochirurgie. Der alleinigen Ganzhirnbestrahlung sind diese Verfahren mit bis zu doppelt so langen Überlebenszeiten deutlich überlegen. Bei multiplen zerebralen Metastasen ist die Ganzhirnbestrahlung die Therapie der Wahl. Sie sollte ebenfalls bei Patienten mit kleinzelligem Bronchialkarzinom Anwendung finden, wo eine Rolle aggressiverer lokaler Therapiemaßnahmen bisher nicht definiert ist. Die systemische Chemotherapie gewinnt beim kleinzelligen und nicht-kleinzelligen Bronchialkarzinom zunehmend an Stellenwert, wobei eine Effektivitätssteigerung durch die simultane Anwendung von Chemo- und Strahlentherapie derzeit in Studien geprüft wird.

Diese Arbeit gibt eine Übersicht über Klinik und Diagnostik sowie daraus ableitbare interdisziplinäre Konzepte für die Behandlung zerebraler Metastasen beim Bronchialkarzinom.

Summary

Cerebral metastases are a frequent complication of lung cancer. They often determine patients’ prognosis and need urgent therapeutic intervention. Based on histologic type, former therapies, age and performance of the patient, the number of cerebral lesions and the extracerebral tumour activity, individualized treatments are applied.

For patients who suffer from non-small cell lung cancer and a single CNS lesion the best results can be achieved if they are surgically resected or receive radiosurgery. Their survival time can be markedly increased in comparison to patients who undergo whole brain irradiation. If multiple metastases are seen in CT or MRI, whole brain irradiation is the therapy to choose. Furthermore it should be initiated if small cell lung cancer metastasizes to the brain. More aggressive local treatment options appear promising, but a clear role for them has not yet been defined. Systemic chemotherapy gains more attention in the treatment of small and non-small cell lung cancer with brain metastases. How to increase the efficacy through simultaneous application of chemo- and radiotherapy is tested in current trials.

This article gives an overview on clinical presentation and diagnosis of cerebral metastases in lung cancer and reviews current treatment options.

Literatur

  • 1 Agboola O, Benoit B, Cross P. et al . Prognostic factors derived from recursive partition analysis (RPA) of radiation therapy oncology group (RTOG) brain metastases trials applied to surgically resected and irradiated brain metastatic cases.  Int J Radiat Oncol Biol Phys. 1998;  42 155-159
    Google Scholar
  • 2 Andrews D W, Scott C B, Sperduto P W. et al . Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial.  Lancet. 2004;  363 1665-1672
    Google Scholar
  • 3 Antonadou D, Paraskevaidis M, Sarris G. et al . Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases.  J Clin Oncol. 2002;  20 3644-3650
    Google Scholar
  • 4 Aoyama H, Shirato H, Nakagawa K, Tago M. Interim report of the JROSG-99 - 1 multi-institutional randomized trial, comparing radiosurgery alone vs. radiosurgery plus whole brain irradiation for 1 - 4 metastases (Presentation data).  Proc ASCO. 2004;  23 108
    Google Scholar
  • 5 Arbit E, Wronski M, Burt M, Galicich J H. The treatment of patients with recurrent brain metastases - A retrospective analysis of 109 patients with nonsmall cell lung cancer.  Cancer. 1995;  76 765-773
    Google Scholar
  • 6 Barker F G. Craniotomy for the resection of metastatic brain tumors in the US, 1988 - 2000.  Cancer. 2004;  100 999-1007
    Google Scholar
  • 7 van den Bent M J. The role of chemotherapy in brain metastases.  Eur J Cancer. 2003;  39 2214-2220
    Google Scholar
  • 8 Bezjak A, Adam J, Barton R. et al . Symptom response after palliative radiotherapy for patients with brain metastases.  Eur J Cancer. 2002;  38 487-496
    Google Scholar
  • 9 Bindal R K, Sawaya R, Leavens M E, Lee J J. Surgical treatment of multiple brain metastases.  J Neurosurg. 1993;  79 210-216
    Google Scholar
  • 10 Bindal A K, Bindal R K, Hess K R. et al . Surgery versus radiosurgery in the treatment of brain metastasis.  J Neurosurg. 1996;  84 748-754
    Google Scholar
  • 11 Bonnette P, Puyo P, Gabriel C. et al . Surgical management of non-small cell lung cancer with synchronous brain metastases.  Chest. 2001;  119 1469-1475
    Google Scholar
  • 12 Bunn P A, Witta S E, Kavanagh B. Brain metastases in small cell lung cancer - The Quan/Videtic/Suh article reviewed.  Oncology (Huntingt). 2004;  18 974-979
    Google Scholar
  • 13 Chen C, Gaspar L E. Brain metastases in small cell lung cancer - The Quan/Videtic/Suh article reviewed.  Oncology (Huntingt). 2004;  18 980-887
    Google Scholar
  • 14 Cortes J, Rodriguez J, Aramendia J M. et al . Front-line paclitaxel/cisplatin-based chemotherapy in brain metastases from non-small-cell lung cancer.  Oncology. 2003;  64 28-35
    Google Scholar
  • 15 Cotto C, Berille J, Souquet P J. et al . A phase II trial of fotemustine and cisplatin in central nervous system metastases from non-small cell lung cancer.  Eur J Cancer. 1996;  32A 69-71
    Google Scholar
  • 16 French L A, Galicich J H. The use of steroids for control of cerebral edema.  Clin Neurosurg. 1964;  10 212-223
    Google Scholar
  • 17 Furuse K, Kamimori T, Kawahara M. et al . A pilot study of concurrent whole-brain radiotherapy and chemotherapy combined with cisplatin, vindesine and mitomycin in non-small-cell lung cancer with brain metastasis.  Br J Cancer. 1997;  75 614-618
    Google Scholar
  • 18 Gaspar L, Scott C, Rotman M. et al . Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials.  Int J Radiat Oncol Biol Phys. 1997;  37 745-751
    Google Scholar
  • 19 Glantz M J, Cole B F, Forsyth P A. et al . Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology.  Neurology. 2000;  54 1886-1893
    Google Scholar
  • 20 Guerrieri M, Wong K, Ryan G. et al . A randomised phase III study of palliative radiation with concomitant carboplatin for brain metastases from non-small cell carcinoma of the lung.  Lung Cancer. 2004;  46 107-111
    Google Scholar
  • 21 Hellwig D, Ukena D, Paulsen F, Bamberg M, Kirsch C -M. Metaanalyse zum Stellenwert der Positronen-Emissionstomographie mit F-18-Fluorodesoxyglukose (PDG-PET) bei Lungentumoren.  Pneumologie. 2001;  55 367-377
    Google Scholar
  • 22 Herth F JF, Eberhardt R. Screeningprogramme für das Bronchialkarzinom - Contra.  Dtsch Med Wochenschr. 2005;  130 467
    Google Scholar
  • 23 Kelly K, Bunn P A. Is it time to reevaluate our approach to the treatment of brain metastases in patients with non-small cell lung cancer?.  Lung Cancer. 1998;  20 85-91
    Google Scholar
  • 24 Korfel A, Oehm C, von Pawel J. et al . Response to topotecan of symptomatic brain metastases of small-cell lung cancer also after whole-brain irradiation: a multicentre phase II study.  Eur J Cancer. 2002;  38 1724-1729
    Google Scholar
  • 25 Komarnicky L T, Phillips T L, Martz K, Asbell S, Isaacson S, Urtasun R. A randomized phase III protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG-7916).  Int J Radiat Oncol Biol Phys. 1991;  20 53-58S>
    Google Scholar
  • 26 Kristjansen P E, Soelberg Sorensen P, Skov Hansen M, Hansen H H. Prospective evaluation of the effect on initial brain metastases from small cell lung cancer of platinum-etoposide based induction chemotherapy followed by an alternating multidrug regimen.  Ann Oncol. 1993;  4 579-583
    Google Scholar
  • 27 Lagerwaard F J, Levendag P C, Nowak P JCM, Eijkenboom W MH, Hanssens P EJ, Schmitz P IM. Identification of prognostic factors in patients with brain metastases: A review of 1292 patients.  Int J Radiat Oncol Biol Phys. 1999;  43 795-803
    Google Scholar
  • 28 Langer C J, Mehta M P. Current management of brain metastases, with a focus on systemic options.  J Clin Oncol. 2005;  23 6207-6219
    Google Scholar
  • 29 Minotti V, Crino L, Meacci M L. et al . Chemotherapy with cisplatin and teniposide for cerebral metastases in non-small cell lung cancer.  Lung Cancer. 1998;  20 93-98
    Google Scholar
  • 30 Mintz A H, Kestle J, Rathbone M P. et al . A Randomized Trial to Assess the Efficacy of Surgery in Addition to Radioctherapy in Patients with a Single Cerebral Metastasis.  Cancer. 1996;  78 1470-1476
    Google Scholar
  • 31 Muacevic A, Kreth F W, Horstmann G A. et al . Surgery and radiotherapy compared with gamma knife radiosurgery in the treatment of solitary cerebral metastases of small diameter.  J Neurosurg. 1999;  91 35-43
    Google Scholar
  • 32 Murray K J, Scott C, Greenberg H M. et al . A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: A report of the Radiation Therapy Oncology Group (RTOG) 9104.  Int J Radiat Oncol Biol Phys. 1997;  39 571-574
    Google Scholar
  • 33 O’Neill B P, Iturria N J, Link M J, Pollock B E, Ballman K V, O’Fallon J R. A comparison of surgical resection and stereotactic radiosurgery in the treatment of solitary brain metastases.  Int J Radiat Oncol Biol Phys. 2003;  55 1169-1176
    Google Scholar
  • 34 Patchell R A, Tibbs P A, Walsh J W. et al . A randomized trial of surgery in the treatment of single metastases to the brain.  N Engl J Med. 1990;  322 494-500
    Google Scholar
  • 35 Patchell R A, Tibbs P A, Regine W F. et al . Postoperative radiotherapy in the treatment of single metastases to the brain - A randomized trial.  JAMA. 1998;  280 1485-1489
    Google Scholar
  • 36 Pfister D G, Johnson D H, Azzoli C G. et al . American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003.  J Clin Oncol. 2004;  22 330-353
    Google Scholar
  • 37 Postmus P E, Haaxma-Reiche H, Smit E F. et al . Treatment of brain metastases of small-cell lung cancer: comparing teniposide and teniposide with whole-brain radiotherapy-a phase III study of the European Organization for the Research and Treatment of Cancer Lung Cancer Cooperative Group.  J Clin Oncol. 2000;  18 3400-3408
    Google Scholar
  • 38 Quan A L, Videtic G MM, Suh J H. Brain metastases in small cell lung cancer.  Oncology (Huntingt). 2004;  18 961-972
    Google Scholar
  • 39 Sawaya R, Ligon B L, Bindal A K, Bindal R K, Hess K R. Surgical treatment of metastatic brain tumors.  J Neurooncol. 1996;  27 269-277
    Google Scholar
  • 40 Schmidt B, Liebers U, Witt C. Screeningprogramme für das Bronchialkarzinom - Pro.  Dtsch Med Wochenschr. 2005;  130 466
    Google Scholar
  • 41 Schouten L J, Rutten J, Huveneers H AM, Twijnstra A. Incidence of Brain Metastases in a Cohort of Patients with Carcinoma of the Breast, Colon, Kidney, and Lung and Melanoma.  Cancer. 2002;  94 2698-2705
    Google Scholar
  • 42 Serizawa T, Ono J, Iichi T. et al . Gamma knife radiosurgery for metastatic brain tumors from lung cancer: a comparison between small cell and non-small cell carcinoma.  J Neurosurg. 2002;  97 484-488
    Google Scholar
  • 43 Seute T, Leffers P, ten Velde G P, Twijnstra A. Neurologic disorders in 432 consecutive patients with small cell lung carcinoma.  Cancer. 2004;  100 801-806
    Google Scholar
  • 44 Shaw E, Scott C, Souhami L. et al . Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90 - 05.  Int J Radiat Oncol Biol Phys. 2000;  47 291-298
    Google Scholar
  • 45 Sheehan J P, Sun M H, Kondziolka D, Flickinger J, Lunsford L D. Radiosurgery for non-small cell lung carcinoma metastatic to the brain: long-term outcomes and prognostic factors influencing patient survival time and local tumor control.  J Neurosurg. 2002;  97 1276-1281
    Google Scholar
  • 46 Simon G R, Wagner H. American College of Chest Physicians: Small cell lung cancer.  Chest. 2003;  123 259S-271S (Suppl 1)
    Google Scholar
  • 47 Sneed P K, Suh J H, Goetsch S J. et al . A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases.  Int J Radiat Oncol Biol Phys. 2002;  53 519-526
    Google Scholar
  • 48 Thomas M, Gatzemeier U, Goerg R. et al . Empfehlungen zur Diagnostik des Bronchialkarzinoms.  Pneumologie. 2000;  54 361-371
    Google Scholar
  • 49 Twelves C J, Souhami R L, Harper P G. et al . The response of cerebral metastases in small cell lung cancer to systemic chemotherapy.  Br J Cancer. 1990;  61 147-150
    Google Scholar
  • 50 Vecht C J, Haaxma-Reiche H, Noordijk E M. et al . Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery?.  Ann Neurol. 1993;  33 583-590
    Google Scholar
  • 51 Verger E, Gil M, Yaya R. et al . Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: a phase II randomized trial.  Int J Radiat Oncol Biol Phys. 2005;  61 185-191
    Google Scholar
  • 52 Wong W W, Schild S E, Sawyer T E, Shaw E G. Analysis of outcome in patients reirradiated for brain metastases.  Int J Radiat Oncol Biol Phys. 1996;  34 585-590
    Google Scholar
  • 53 Yokoi K, Kamiya N, Matsuguma H. et al . Detection of brain metastasis in potentially operable non-small cell lung cancer - A comparison of CT and MRI.  Chest. 1999;  115 714-719
    Google Scholar

Dr. med. Daniel Binder

Medizinische Klinik m. S. Infektiologie und Pneumologie, Charite - Universitätsmedizin Berlin

Augustenburger Platz 1

13353 Berlin

Phone: 030/450553388

Fax: 030/450553911

Email: daniel.binder@charite.de

      >